Shares of Savaria Co. (TSE:SIS – Get Free Report) have earned an average recommendation of “Buy” from the six research firms that are presently covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have issued a report on the stock in the last year is C$23.83.
A number of equities analysts recently commented on the company. Cormark upgraded Savaria from a “hold” rating to a “moderate buy” rating in a report on Friday, March 7th. Desjardins dropped their price objective on shares of Savaria from C$27.00 to C$25.00 and set a “buy” rating for the company in a report on Friday, March 7th. Scotiabank cut their target price on shares of Savaria from C$25.00 to C$22.00 and set an “outperform” rating on the stock in a research note on Friday, March 7th. National Bankshares decreased their price target on shares of Savaria from C$27.00 to C$24.00 and set an “outperform” rating for the company in a research report on Friday, March 7th. Finally, Raymond James Financial cut their price objective on Savaria from C$27.50 to C$24.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th.
Check Out Our Latest Report on SIS
Savaria Price Performance
Insider Activity at Savaria
In other news, Director Alain Tremblay sold 10,000 shares of Savaria stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of C$19.61, for a total transaction of C$196,092.00. 17.45% of the stock is currently owned by corporate insiders.
About Savaria
Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company’s operating segments are the Accessibility, Adapted Vehicles, and Patient Handling, divisions.
Featured Articles
- Five stocks we like better than Savaria
- Insider Trades May Not Tell You What You Think
- AutoNation: Growth Engines Make It an Undervalued Stock
- Asset Allocation Strategies in Volatile Markets
- Snowflake Hits 52-Week High—Options Traders Bet on Further Rally
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.